1st Quarter - Report

GILBERT'S LLP for MYLAN LABORATORIES INC

Firm
Client
Income
$75,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Consumer Issues/Safety/Products CSP

Reform to legislation and regulations affecting pharmaceutical drug approval and marketing

LobbyistCovered position, as disclosed
TIM GILBERT —
NATHANIEL BRANDON LIPKUS —
JOCELYN MACKIE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC)

Health Issues HCR

Reform to legislation and regulations affecting pharmaceutical drug approval and marketing

LobbyistCovered position, as disclosed
TIM GILBERT —
NATHANIEL BRANDON LIPKUS —
JOCELYN MACKIE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Federal Trade Commission (FTC)

Pharmacy PHA

Reform to legislation and regulations affecting pharmaceutical drug approval and marketing

LobbyistCovered position, as disclosed
TIM GILBERT —
NATHANIEL BRANDON LIPKUS —
JOCELYN MACKIE —

Contacted: SENATE; Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.